Quote | Entheon Biomedical Corp Com (OTCMKTS:ENTBF)
Last: | $0.121 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.121 |
High: | $0 |
Low: | $0 |
Volume: | 85 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Entheon Biomedical Corp Com (OTCMKTS:ENTBF)
2024-03-27 17:08:02 ET Addiction is an issue that affects a significant number of people worldwide. While conventional treatments have existed for decades, they offer a very low rate of efficacy, often as low as 5%. For Timothy Ko , CEO of Entheon Biomedical , the problem ...
2024-03-27 17:08:02 ET Leading-edge addiction recovery solution Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorde...
Message Board Posts | Entheon Biomedical Corp Com (OTCMKTS:ENTBF)
Subject | By | Source | When |
---|---|---|---|
Gap at .03 next to fill, then news hopefully | StockLogistics | investorshub | 08/31/2022 1:21:44 PM |
Need Elon to invest in psychedelics | StockLogistics | investorshub | 08/23/2022 2:06:24 PM |
Getting better each day | StockLogistics | investorshub | 08/18/2022 11:12:43 PM |
Cup and handle | StockLogistics | investorshub | 08/18/2022 2:17:46 AM |
Entheon and Elon ? | StockLogistics | investorshub | 08/14/2022 2:10:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Entheon Biomedical Corp Com Company Name:
ENTBF Stock Symbol:
OTCMKTS Market:
2024-03-27 17:08:02 ET Addiction is an issue that affects a significant number of people worldwide. While conventional treatments have existed for decades, they offer a very low rate of efficacy, often as low as 5%. For Timothy Ko , CEO of Entheon Biomedical , the problem ...
2024-03-27 17:08:02 ET Leading-edge addiction recovery solution Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorde...
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) , a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fel...